-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Head to Head Survey: UpHealth (UPH) Vs. Its Peers
Head to Head Survey: UpHealth (UPH) Vs. Its Peers
UpHealth (NYSE:UPH – Get Rating) is one of 33 public companies in the "Health services" industry, but how does it contrast to its competitors? We will compare UpHealth to related businesses based on the strength of its institutional ownership, dividends, valuation, earnings, profitability, analyst recommendations and risk.
Risk and Volatility
UpHealth has a beta of 0.19, suggesting that its share price is 81% less volatile than the S&P 500. Comparatively, UpHealth's competitors have a beta of 1.20, suggesting that their average share price is 20% more volatile than the S&P 500.
Get UpHealth alerts:Analyst Recommendations
This is a summary of recent recommendations and price targets for UpHealth and its competitors, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| UpHealth | 0 | 1 | 1 | 0 | 2.50 |
| UpHealth Competitors | 7 | 130 | 275 | 0 | 2.65 |
Earnings & Valuation
This table compares UpHealth and its competitors top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| UpHealth | $123.79 million | -$340.90 million | -0.15 |
| UpHealth Competitors | $1.36 billion | -$98.47 million | 30.90 |
UpHealth's competitors have higher revenue and earnings than UpHealth. UpHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Institutional & Insider Ownership
48.6% of shares of all "Health services" companies are held by institutional investors. 41.3% of UpHealth shares are held by insiders. Comparatively, 21.6% of shares of all "Health services" companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares UpHealth and its competitors' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| UpHealth | -204.99% | -18.80% | -11.75% |
| UpHealth Competitors | -325.87% | -481.74% | -38.64% |
Summary
UpHealth competitors beat UpHealth on 7 of the 12 factors compared.
UpHealth Company Profile
(Get Rating)
UpHealth, Inc. operates as a digital health services company. It provides a patient-centric digital health technologies and tech-enabled services to manage health and integrate care in the areas of integrated care management, virtual care infrastructure, and services. The company's solutions include Syntranet Core Platform, an integrated care management platform; Cloudbreak, a provider of unified telemedicine solutions and digital health tools; HelloLyf from Glocal, a platform that delivers primary care and specialty consultations; and MedQuest Pharmacy, a full-service retail and compounding licensed pharmacy that dispenses prescribed medications shipped directly to patients. UpHealth, Inc. is headquartered in Delray Beach, Florida.
Receive News & Ratings for UpHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UpHealth and related companies with MarketBeat.com's FREE daily email newsletter.
UpHealth (NYSE:UPH – Get Rating) is one of 33 public companies in the "Health services" industry, but how does it contrast to its competitors? We will compare UpHealth to related businesses based on the strength of its institutional ownership, dividends, valuation, earnings, profitability, analyst recommendations and risk.
UpHealth(NYSE：UPH-GET Rating)是“健康服務”行業的33家上市公司之一，但它與競爭對手相比有何不同？我們將根據UpHealth的機構所有權、股息、估值、收益、盈利能力、分析師建議和風險等方面的優勢，將UpHealth與相關業務進行比較。
Risk and Volatility
風險和波動性
UpHealth has a beta of 0.19, suggesting that its share price is 81% less volatile than the S&P 500. Comparatively, UpHealth's competitors have a beta of 1.20, suggesting that their average share price is 20% more volatile than the S&P 500.
UpHealth的貝塔係數為0.19，這表明其股價的波動性比標準普爾500指數低81%。相比之下，UpHealth的競爭對手的貝塔係數為1.20，這表明它們的平均股價波動性比標準普爾500指數高20%。
Analyst Recommendations
分析師建議
This is a summary of recent recommendations and price targets for UpHealth and its competitors, as provided by MarketBeat.com.
這是對UpHealth及其競爭對手最近的建議和目標價的摘要，由MarketBeat.com提供。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| UpHealth | 0 | 1 | 1 | 0 | 2.50 |
| UpHealth Competitors | 7 | 130 | 275 | 0 | 2.65 |
| 銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
| UpHealth | 0 | 1 | 1 | 0 | 2.50 |
| UpHealth競爭對手 | 7 | 130 | 275 | 0 | 2.65 |
Earnings & Valuation
收益與估值
This table compares UpHealth and its competitors top-line revenue, earnings per share and valuation.
此表比較了UpHealth及其競爭對手的營收、每股收益和估值。
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| UpHealth | $123.79 million | -$340.90 million | -0.15 |
| UpHealth Competitors | $1.36 billion | -$98.47 million | 30.90 |
| 總收入 | 淨收入 | 市盈率 | |
| UpHealth | 1.2379億美元 | -3.409億美元 | -0.15 |
| UpHealth競爭對手 | 13.6億美元 | -9,847萬元 | 30.90 |
UpHealth's competitors have higher revenue and earnings than UpHealth. UpHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
UpHealth的競爭對手比UpHealth的收入和收益更高。UpHealth的市盈率低於競爭對手，這表明它目前比行業內的其他公司更負擔得起。
Institutional & Insider Ownership
機構與內部人持股
48.6% of shares of all "Health services" companies are held by institutional investors. 41.3% of UpHealth shares are held by insiders. Comparatively, 21.6% of shares of all "Health services" companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
所有“健康服務”公司48.6%的股份由機構投資者持有。UpHealth 41.3%的股份由內部人士持有。相比之下，所有“健康服務”公司21.6%的股份由內部人持有。強大的機構持股表明，捐贈基金、對衝基金和大型基金管理公司相信，一隻股票的長期表現將好於大盤。
Profitability
盈利能力
This table compares UpHealth and its competitors' net margins, return on equity and return on assets.
此表比較了UpHealth及其競爭對手的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| UpHealth | -204.99% | -18.80% | -11.75% |
| UpHealth Competitors | -325.87% | -481.74% | -38.64% |
| 淨利潤率 | 股本回報率 | 資產回報率 | |
| UpHealth | -204.99% | -18.80% | -11.75% |
| UpHealth競爭對手 | -325.87% | -481.74% | -38.64% |
Summary
摘要
UpHealth competitors beat UpHealth on 7 of the 12 factors compared.
在比較的12個因素中，UpHealth的競爭對手在7個方面擊敗了UpHealth。
UpHealth Company Profile
UpHealth公司簡介
(Get Rating)
(獲取評級)
UpHealth, Inc. operates as a digital health services company. It provides a patient-centric digital health technologies and tech-enabled services to manage health and integrate care in the areas of integrated care management, virtual care infrastructure, and services. The company's solutions include Syntranet Core Platform, an integrated care management platform; Cloudbreak, a provider of unified telemedicine solutions and digital health tools; HelloLyf from Glocal, a platform that delivers primary care and specialty consultations; and MedQuest Pharmacy, a full-service retail and compounding licensed pharmacy that dispenses prescribed medications shipped directly to patients. UpHealth, Inc. is headquartered in Delray Beach, Florida.
UpHealth，Inc.是一家數字健康服務公司。它提供以患者為中心的數字醫療技術和技術支持的服務，以管理健康並在綜合醫療管理、虛擬醫療基礎設施和服務領域整合醫療。該公司的解決方案包括綜合護理管理平臺Syntranet Core Platform；統一遠程醫療解決方案和數字健康工具提供商CloudBreak；提供初級保健和專科諮詢的平臺Glocal的HelloLyf；以及直接向患者分發處方藥的全方位服務零售和複方許可藥房MedQuest Pharmacy。UpHealth，Inc.總部設在佛羅裏達州的德爾雷海灘。
Receive News & Ratings for UpHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UpHealth and related companies with MarketBeat.com's FREE daily email newsletter.
接受UpHealth Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對UpHealth和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧